CELU celularity.com: ערך חשבונאי למניה

As an innovator in tissue regeneration, Celularity Inc. strives to make cancer therapy more accessible. This daily price chart from the GURU.Markets platform reflects the bvps trend, where the current figure stands at -1.21. Stability is provided by a mix of commercial sales and clinical trials, while biobanking optimization allows for a reduction in unit production costs for cellular products.

Celularity Inc. is advancing the commercialization of placental cell-based therapeutic solutions, making the estimated book value per share an indicator of the efficiency of intellectual asset capitalization. This metric reflects the portion of net assets attributable to a single share, allowing investors to assess the real value of the business net of liabilities and determine the degree of capital preservation during the R&D period.